Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Q2 2021 EPS Estimates for Santander Consumer USA Holdings Inc. (NYSE:SC) Raised by Piper Sandler

researchsnappy by researchsnappy
July 5, 2021
in Consumer Research
0
FY2019 EPS Estimates for Santander Consumer USA Holdings Inc Reduced by Piper Jaffray Companies (NYSE:SC)
401
SHARES
2.4k
VIEWS
Share on FacebookShare on Twitter

Santander Consumer USA logo

Santander Consumer USA Holdings Inc. (NYSE:SC) – Stock analysts at Piper Sandler lifted their Q2 2021 earnings per share estimates for shares of Santander Consumer USA in a research note issued on Friday, July 2nd. Piper Sandler analyst K. Barker now forecasts that the financial services provider will post earnings of $2.40 per share for the quarter, up from their previous estimate of $2.26. Santander Consumer USA (NYSE:SC) last announced its quarterly earnings results on Wednesday, April 28th. The financial services provider reported $2.42 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.45 by $0.97. The business had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.29 billion. Santander Consumer USA had a return on equity of 30.33% and a net margin of 20.43%. The firm’s revenue was up 19.3% on a year-over-year basis. During the same period in the previous year, the company earned ($0.01) EPS.

Other research analysts also recently issued reports about the company. Bank of America began coverage on Santander Consumer USA in a research report on Monday, April 12th. They issued a “buy” rating and a $36.00 price target on the stock. Deutsche Bank Aktiengesellschaft began coverage on Santander Consumer USA in a research report on Wednesday, May 26th. They issued a “buy” rating and a $41.00 price target on the stock. Zacks Investment Research downgraded Santander Consumer USA from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 30th. Compass Point downgraded Santander Consumer USA from a “buy” rating to a “neutral” rating and lifted their price target for the stock from $35.00 to $39.00 in a research report on Friday. Finally, JPMorgan Chase & Co. lifted their price target on Santander Consumer USA from $27.00 to $29.00 in a research report on Thursday, April 15th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $32.40.

(Ad)

Get real-time analyst ratings, earnings, dividends, headlines, and SEC filings. Access unbeatable research tools, stock screeners and research reports.

Shares of SC stock opened at $40.56 on Monday. The firm has a 50 day moving average of $36.53. The company has a debt-to-equity ratio of 6.18, a current ratio of 51.93 and a quick ratio of 51.93. Santander Consumer USA has a twelve month low of $16.03 and a twelve month high of $41.10. The company has a market cap of $12.41 billion, a P/E ratio of 7.51, a price-to-earnings-growth ratio of 0.32 and a beta of 1.09.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 20th. Investors of record on Monday, May 10th were issued a $0.22 dividend. The ex-dividend date was Friday, May 7th. This represents a $0.88 dividend on an annualized basis and a yield of 2.17%. Santander Consumer USA’s dividend payout ratio is presently 30.66%.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BlackRock Inc. increased its holdings in shares of Santander Consumer USA by 80.0% in the fourth quarter. BlackRock Inc. now owns 5,622,454 shares of the financial services provider’s stock worth $123,806,000 after acquiring an additional 2,498,737 shares in the last quarter. Rubric Capital Management LP bought a new stake in shares of Santander Consumer USA in the first quarter worth about $42,257,000. Norges Bank bought a new stake in shares of Santander Consumer USA in the fourth quarter worth about $21,026,000. WS Management Lllp bought a new stake in shares of Santander Consumer USA in the first quarter worth about $18,131,000. Finally, Philadelphia Financial Management of San Francisco LLC acquired a new position in shares of Santander Consumer USA during the first quarter worth about $13,908,000. Institutional investors and hedge funds own 99.86% of the company’s stock.

Santander Consumer USA Company Profile

Santander Consumer USA Holdings Inc, a specialized consumer finance company, provides vehicle finance and third-party servicing in the United States. It offers vehicle financial products and services, including retail installment contracts and vehicle leases, as well as dealer loans for inventory, construction, real estate, working capital, and revolving lines of credit.

Featured Story: Fundamental Analysis

Earnings History and Estimates for Santander Consumer USA (NYSE:SC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: What is a dividend reinvestment plan?

7 Healthcare Stocks Delivering Innovation in 2021

We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.

Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.

However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.

View the “7 Healthcare Stocks Delivering Innovation in 2021”.

Previous Post

Fund-raise key for SpiceJet to ensure long-term survival

Next Post

Share Market Today LIVE | Sensex, Nifty, BSE, NSE, Share Prices, Stock Market News Updates July 5

Next Post
Share Market Today LIVE | Sensex, Nifty, BSE, NSE, Share Prices, Stock Market News Updates July 5

Share Market Today LIVE | Sensex, Nifty, BSE, NSE, Share Prices, Stock Market News Updates July 5

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com